Results for tag: "Marburg Hemorrhagic Fever Drug"

Marburg Hemorrhagic Fever (MHF) is a rare and severe type of viral hemorrhagic fever caused by the Marburg virus. It is a rare disease, with only a few hundred cases reported since its discovery in 1967. Treatment for MHF is limited and there is no specific drug available. However, supportive care and antiviral drugs can be used to reduce the severity of the disease. The MHF drug market is a small but growing market, with a few companies developing drugs to treat the disease. These companies are focusing on developing antiviral drugs, as well as supportive care treatments. The development of these drugs is still in its early stages, and there is a need for more research and development in this area. Some companies in the MHF drug market include Gilead Sciences, Inc., Merck & Co., Inc., and GlaxoSmithKline plc. These companies are researching and developing drugs to treat MHF, as well as other infectious diseases. Show Less Read more